Start for free
Start for free
Syno Capital logo

Syno Capital

North America, New York, United States, New York

Description

Syno Capital is a principal investment firm focused on life science and healthcare sector investments in New York.

Investor Profile

Syno Capital has made 8 investments, with 0 in the past 12 months and 13% as lead.

Stage Focus

  • Series B (50%)
  • Series A (25%)
  • Series Unknown (13%)
  • Series D (13%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Personal Health
  • Wellness
  • Pharmaceutical
  • Elder Care
  • Home Health Care
  • Life Science
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Syno Capital frequently co-invest with?

Mountain Group Capital
Mountain Group Capital
North America, Tennessee, United States, Nashville
Co-Investments: 2
E Squared Capital Management
E Squared Capital Management
North America, New York, United States, New York
Co-Investments: 2
Hatteras Venture Partners
Hatteras Venture Partners
North America, North Carolina, United States, Durham
Co-Investments: 3
LabCorp
LabCorp
North America, North Carolina, United States, Burlington
Co-Investments: 2
Alexandria Venture Investments
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 3
8VC
8VC
North America, California, United States, San Francisco
Co-Investments: 1
180 Degree Capital
180 Degree Capital
North America, New Jersey, United States, Montclair
Co-Investments: 2
DEFTA Partners
DEFTA Partners
North America, California, United States, San Francisco
Co-Investments: 2
KF
KTB-KORUS Fund
Asia, Kyonggi-do, South Korea, Seongnam
Co-Investments: 2
EF
Co-Investments: 2

Which angels does Syno Capital often collaborate with?

SS
Steve Seigel
North America, California, United States, Los Angeles
Shared Deals: 1
Derek Schueren
Derek Schueren
North America, California, United States, San Francisco
Shared Deals: 1
FB
Franklin Berger
North America, New York, United States, New York
Shared Deals: 2

What are some of recent deals done by Syno Capital?

Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series BFeb 1, 2019
Amount Raised: $25,000,000
PhaseBio Pharmaceuticals

Malvern, Pennsylvania, United States

PhaseBio is a clinical-stage biopharmaceutical company that develops drugs for cardiovascular diseases, endocrine, and metabolic disorders.

BiotechnologyMedicalMedical DevicePharmaceutical
Series DSep 5, 2018
Amount Raised: $34,000,000
TCR2

Cambridge, Massachusetts, United States

TCR2 is a discovery stage pharmaceutical company that developed a unique proprietary TRuC™ platform.

BiotechnologyHealth CareLife ScienceMedicalPharmaceuticalTherapeutics
Series BMar 21, 2018
Amount Raised: $125,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series UnknownJun 27, 2017
Amount Raised: $20,000,000
Applied Therapeutics

New York, New York, United States

Applied Therapeutics uses drug-development approach to target molecules and pathways that has roles in fatal or debilitating diseases.

BiotechnologyHealth CareTherapeuticsWellness
Series AFeb 8, 2017
Amount Raised: $6,067,875
Honor

Concord, California, United States

Honor is a senior care network and technology platform that offers personalized care to improve the in-home care experience.

Elder CareHealth CareHome Health CareMedical
Series BAug 5, 2016
Amount Raised: $45,000,000
ORIG3N

Boston, Massachusetts, United States

ORIG3N is a biotechnology company developing breakthrough treatments for rare genetically inherited diseases.

BiotechnologyHealth CareMedicalPersonal Health
Series ADec 12, 2015
Amount Raised: $12,500,000
LungLife AI

Thousand Oaks, California, United States

LungLife AI is a molecular diagnostics company that involves in the early detection and treatment of cancer.

Artificial Intelligence (AI)BiotechnologyHealth DiagnosticsMachine LearningMedical
Series BJun 17, 2015
Amount Raised: $25,500,000
c-shape-1
c-shape-2

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Find investorsPricing

Free tools

Pre-Money and Post-Money Valuation Calculator